The synthetic compound RP-182 enabled macrophages (grey) to better engulf cancer cells (green) compared to untreated macrophages. This material relates to a paper that appeared in the Feb. 12, 2020, issue of Science Translational Medicine, published by AAAS. The paper, by J.M. Jaynes at Tuskegee University in Tuskegee, AL; and colleagues was titled, "Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses."
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact Science for permission.